Long-term outcomes with haloperidol versus placebo in acutely admitted adult ICU patients with delirium.
Camilla Bekker MortensenNina Christine Andersen-RanbergLone Musaeus PoulsenAnders GranholmBodil Steen RasmussenMaj-Brit Nørerregaard KjaerTheis LangeBjørn H EbdrupMarie Oxenbøll ColletAnne Sofie AndreasenMorten Heiberg BestleBülent UsluHelle Scharling PedersenLouise Gramstrup NielsenJohanna HästbackaTroels Bek JensenKjeld DamgaardTrine SommerMatthew MorgenNilanjan DeyGuiseppe CiterioStine EstrupIngrid EgerodKarin SamuelsonAnders PernerOle MathiesenPublished in: Intensive care medicine (2024)
In acutely admitted adult ICU patients with delirium, haloperidol treatment reduced mortality at 1-year follow-up, but did not statistically significantly improve HRQoL.
Keyphrases
- intensive care unit
- cardiac surgery
- mechanical ventilation
- hip fracture
- cardiovascular events
- risk factors
- clinical trial
- randomized controlled trial
- acute kidney injury
- coronary artery disease
- double blind
- acute respiratory distress syndrome
- combination therapy
- phase iii
- young adults
- placebo controlled
- smoking cessation